User login
We are all aware of the burden of psoriatic arthritis (PsA). Although psoriasis is more common, the arthritic component is a major factor in the morbidity of psoriatic disease. Accordingly, the National Psoriasis Foundation (NPF) is taking steps to expand the focus on PsA.
Last month, the NPF launched the largest realignment and expansion of its PsA program since the organization began its services almost 20 years ago. The NPF’s PsA Project will focus on 4 major areas: (1) Decrease the time to diagnosis. (2) Help those with PsA better manage their disease. (3) Reduce barriers to health care and treatments. (4) Improve understanding of PsA symptoms, disease management, and impact on patient quality of life among health care providers.
Through the PsA Project, the NPF has the following specific goals: (1) Reduce the average time of diagnosis of PsA from 4 years to 1 year. (2) Increase by 50% the number of people with PsA who are receiving the right treatment to 62% total. (3) Reduce from 50% to 30% the number of people who report PsA is a problem in their everyday lives. (4) Double the number of health resources available to people diagnosed with PsA. (5) Increase by 50% the number of National Institutes of Health–funded scientists studying psoriatic disease to 42 scientists to boost care, improve treatment, and find a cure for PsA.
What’s the issue?
Our patients with PsA deserve more resources. The earlier we diagnose this condition the less likely an individual is to suffer pain and possible joint destruction. A project such as the one created by the NPF can only help to raise awareness among both patients and physicians. How will you contribute to expanding awareness of psoriatic arthritis in your community?
We are all aware of the burden of psoriatic arthritis (PsA). Although psoriasis is more common, the arthritic component is a major factor in the morbidity of psoriatic disease. Accordingly, the National Psoriasis Foundation (NPF) is taking steps to expand the focus on PsA.
Last month, the NPF launched the largest realignment and expansion of its PsA program since the organization began its services almost 20 years ago. The NPF’s PsA Project will focus on 4 major areas: (1) Decrease the time to diagnosis. (2) Help those with PsA better manage their disease. (3) Reduce barriers to health care and treatments. (4) Improve understanding of PsA symptoms, disease management, and impact on patient quality of life among health care providers.
Through the PsA Project, the NPF has the following specific goals: (1) Reduce the average time of diagnosis of PsA from 4 years to 1 year. (2) Increase by 50% the number of people with PsA who are receiving the right treatment to 62% total. (3) Reduce from 50% to 30% the number of people who report PsA is a problem in their everyday lives. (4) Double the number of health resources available to people diagnosed with PsA. (5) Increase by 50% the number of National Institutes of Health–funded scientists studying psoriatic disease to 42 scientists to boost care, improve treatment, and find a cure for PsA.
What’s the issue?
Our patients with PsA deserve more resources. The earlier we diagnose this condition the less likely an individual is to suffer pain and possible joint destruction. A project such as the one created by the NPF can only help to raise awareness among both patients and physicians. How will you contribute to expanding awareness of psoriatic arthritis in your community?
We are all aware of the burden of psoriatic arthritis (PsA). Although psoriasis is more common, the arthritic component is a major factor in the morbidity of psoriatic disease. Accordingly, the National Psoriasis Foundation (NPF) is taking steps to expand the focus on PsA.
Last month, the NPF launched the largest realignment and expansion of its PsA program since the organization began its services almost 20 years ago. The NPF’s PsA Project will focus on 4 major areas: (1) Decrease the time to diagnosis. (2) Help those with PsA better manage their disease. (3) Reduce barriers to health care and treatments. (4) Improve understanding of PsA symptoms, disease management, and impact on patient quality of life among health care providers.
Through the PsA Project, the NPF has the following specific goals: (1) Reduce the average time of diagnosis of PsA from 4 years to 1 year. (2) Increase by 50% the number of people with PsA who are receiving the right treatment to 62% total. (3) Reduce from 50% to 30% the number of people who report PsA is a problem in their everyday lives. (4) Double the number of health resources available to people diagnosed with PsA. (5) Increase by 50% the number of National Institutes of Health–funded scientists studying psoriatic disease to 42 scientists to boost care, improve treatment, and find a cure for PsA.
What’s the issue?
Our patients with PsA deserve more resources. The earlier we diagnose this condition the less likely an individual is to suffer pain and possible joint destruction. A project such as the one created by the NPF can only help to raise awareness among both patients and physicians. How will you contribute to expanding awareness of psoriatic arthritis in your community?
